ID

27528

Beskrivning

Study part: Concomitant Medication Treatment Phase. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Nyckelord

Versioner (1)
  1. 2017-11-19 2017-11-19 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

19 november 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Concomitant Medication Treatment Phase Ropinirole Parkinson Disease 101468/165

Engelsk

Concomitant Medication Treatment Phase

1 Formulär  
CONCOMITANT MEDICATION
Beskrivning

CONCOMITANT MEDICATION

Alias
UMLS CUI-1
C2347852
Patient Number
Beskrivning

Patient Number

Datatyp

integer

Alias
UMLS CUI [1]
C1830427
Are there any concomitant medication changes since the start of the study?
Beskrivning

Concomitant Medication

Datatyp

boolean

Alias
UMLS CUI [1]
C2347852
Drug Name
Beskrivning

Drug Name

Datatyp

text

Alias
UMLS CUI [1]
C0013227
Single dose/Unit
Beskrivning

Single dose

Datatyp

text

Alias
UMLS CUI [1]
C1960417
Frequency of this dose
Beskrivning

dose frequency

Datatyp

text

Alias
UMLS CUI [1]
C2826654
Route
Beskrivning

Route

Datatyp

text

Alias
UMLS CUI [1]
C0013153
Indication
Beskrivning

Indication

Datatyp

text

Alias
UMLS CUI [1]
C3146298
Start Date/Time
Beskrivning

Start Date and Time

Datatyp

datetime

Alias
UMLS CUI [1]
C3897500
End Date/Time
Beskrivning

End Date and Time

Datatyp

datetime

Alias
UMLS CUI [1]
C3899266
Tillbaka till toppen

Similar models

Concomitant Medication Treatment Phase

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
CONCOMITANT MEDICATION
C2347852 (UMLS CUI-1)
Patient Number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Concomitant Medication
Item
Are there any concomitant medication changes since the start of the study?
boolean
C2347852 (UMLS CUI [1])
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Single dose
Item
Single dose/Unit
text
C1960417 (UMLS CUI [1])
dose frequency
Item
Frequency of this dose
text
C2826654 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
Start Date and Time
Item
Start Date/Time
datetime
C3897500 (UMLS CUI [1])
End Date and Time
Item
End Date/Time
datetime
C3899266 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial